Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

News SummaryMost relevantAll newsSector newsTweets

CIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With Anthem

share with twitter share with LinkedIn share with facebook
share via e-mail
02/16/2017 | 03:32pm CEST
By Brent Kendall 

A Delaware judge on Wednesday issued a temporary restraining order that blocks Cigna Corp. from immediately terminating its troubled $48 billion merger with rival health insurer Anthem Inc.

The development is the latest in what could be a long and bitter legal battle between the two companies in the wake of a federal judge's ruling earlier this month that the proposed merger violates U.S. antitrust law.

Cigna on Tuesday declared it was done with the merger and sued Anthem, seeking a $1.85 billion breakup fee plus more than $13 billion in damages from its deal partner. Anthem then responded with its own lawsuit and sought an immediate order stopping Cigna from ending their pact.

Anthem obtained such an order Wednesday from Vice Chancellor J. Travis Laster, a judge on the Delaware Chancery Court, according to a Thursday filing by Cigna with the Securities and Exchange Commission.

Under the terms of the merger agreement, Anthem could extend the deal until the end of April. The firm is making a long-shot bid to win a quick appeal of U.S. District Judge Amy Berman Jackson's ruling that the merger would unlawfully harm consumers and competition.

Both Anthem and Cigna have accused one another of violating their 2015 merger deal. Cigna said Anthem's alleged violations meant it couldn't extend the merger agreement until April. Anthem said Cigna has been engaged in a campaign to sink the deal.

Cigna in a statement said, "This is not a decision on the merits of the case, but rather a procedural order to ensure irrevocable actions do not take place before the court's substantive review of the issues. Cigna respects the court's decision and will continue to abide by terms of the merger agreement until the court further reviews the case."

The insurer said another hearing will be scheduled the week of April 10.

Anthem didn't respond to a request for comment on the restraining order.

Write to Brent Kendall at [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
10/19 CIGNA CORPORATION (NYSE : CI) Files An 8-K Departure of Directors or Certain Off..
10/18 CIGNA CORP : Change in Directors or Principal Officers, Financial Statements and..
10/18 CIGNA FOUNDATION : and Ghetto Film School Announce Winners of Filmmaking Competi..
10/18DJHealth Insurers Step Up Open Enrollment Push As Window to Sign Up Shrinks
10/16 CIGNA-HEALTHSPRING : ’s Medicare Advantage Plans for 2018 Emphasize Afford..
10/11DJCompanies Ask Supreme Court to Hear Gay-Rights Case
10/10 CIGNA : Delta Dental of Virginia names new president
10/04 CIGNA IS COMMITTED TO REDUCING OPIOI : Removing OxyContin from Group Commercial ..
10/04 CIGNA CORPORATION : ’s Third Quarter 2017 Earnings Release Details
10/03 CIGNA : Assists People Affected by Las Vegas Shooting With Free 24x7 Telephone H..
More news
News from SeekingAlpha
10/19 Bipartisan bill to shore up ACA gaining support, 12 Republicans on board
10/18 Trump not on board with bipartisan Senate deal on Obamacare, bill stalled
10/18 UnitedHealth Faces 50% Share Drop Or Worse
10/17 Healthcare sector on the move after Senate deal
10/17 Premarket analyst action - healthcare
Financials ($)
Sales 2017 41 059 M
EBIT 2017 3 456 M
Net income 2017 2 425 M
Debt 2017 417 M
Yield 2017 0,01%
P/E ratio 2017 20,44
P/E ratio 2018 17,78
EV / Sales 2017 1,18x
EV / Sales 2018 1,16x
Capitalization 48 195 M
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 196 $
Spread / Average Target 2,6%
EPS Revisions
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Eric Palmer Chief Financial Officer
Alan M. Muney Chief Medical Officer
Mark L. Boxer Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC27.12%52 283
ANTHEM INC33.40%50 361
HUMANA INC18.95%34 873
CENTENE CORP67.58%16 133